Who invested in MISSION Therapeutics?
MISSION Therapeutics's investors include Sofinnova Partners, SR One, Innovate UK, Roche Venture Fund and IP Group, and 2 more on record.

United Kingdom · Venture startup
Funding summaryUpdated 26 Oct 2026
$113Mraised across 5 rounds since 2011, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Reported by 4-traders.com
Reported by biospace.com
MISSION Therapeutics filed 2 raises, $70M in all. Filings say how much was sold and to how many investors; they never name the investors.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
MISSION Therapeutics's investors include Sofinnova Partners, SR One, Innovate UK, Roche Venture Fund and IP Group, and 2 more on record.
MISSION Therapeutics has raised $113M across 5 rounds since 2011.
MISSION Therapeutics's most recent round was a Venture of $13M in Oct 2025.
MISSION Therapeutics's largest round on record is $56M, in Mar 2024.
MISSION Therapeutics's first round on record, in Aug 2011, was backed by Sofinnova Partners, SR One and Imperial Innovations Investment Management and 1 others.
MISSION Therapeutics's latest named round is a Venture, in Oct 2025.
MISSION Therapeutics is based in the United Kingdom.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.